"University of Pennsylvania researchers found that the protein GPNMB facilitates the spread of Parkinson's-related damage. Blocking GPNMB with monoclonal antibodies could potentially slow disease progression. The study suggests GPNMB is produced by microglia in response to neuronal damage."